Infliximab-induced vitiligo

Dermatology

Volumn 210, Issue 1, 2005, Pages 79-80

  Ramírez Hernández, Mercedes ^a   Marras, Carlos ^a   Martínez Escribano, Jorge A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Infliximab; Tumor necrosis factor ; Vitiligo

Indexed keywords

FOLINIC ACID; INFLIXIMAB; MELOXICAM; METHOTREXATE; PLANT EXTRACT; POLYPODIUM LEUCOTOMOS EXTRACT; PREDNISONE;

ADULT; ANAMNESIS; ANTIBODY TITER; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; HUMAN; HYPOPIGMENTATION; INFUSION; LABORATORY TEST; MALE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT WITHDRAWAL; URINALYSIS; VITILIGO;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; VITILIGO;

EID: 10644297947     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081494     Document Type: Article

References (9)

1. Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC: Cutaneous drug eruption to infliximab: Report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002;138:1258-1259.
2. Al-Salem IH: Striking and rapid improvement of plaque psoriasis with infliximab. Dermatology 2003;207:54-56.
3. Arslan S, Kav T, Besisik F, Kaymakoglu S, Pinarbasi B, Tözün N, et al: Clinical outcome of Crohn's disease treated with infliximab. Hepatogastroenterology 2003;50:952-956.
4. Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C, et al: Efficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitides: An open pilot study on 10 patients. Rheumatology 2002;41:1126-1132.
5. Stephens MC, Shepanski MA, Mamula P, Markowitz JE, Brown KA, Baldassano RN: Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol 2003;98:104-111.
6. Devos SA, Van Den Bossche N, De Vos M, Naeyaert JM: Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology 2003;206:388-390.
7. Mahè E, Descamps V, Grossin M, Fraitag S, Crickx B: CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol 2003;149:170-173.
8. Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, et al: Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn's disease: A prospective cohort study. Gastroenterology 2003;125:32-39.
9. Colombel JF, Loftus EV, Tremaine WJ, Egan LJ, Harmsen WS, Scheleck CD, et al: The safety profile of infliximab in patients with Crohn's disease: The Mayo clinic experience in 500 patients. Gastroenterology 2004;126:19-31.